These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10644909)

  • 21. Blocking VLA-4 prevents progression of experimental crescentic glomerulonephritis.
    Khan SB; Allen AR; Bhangal G; Smith J; Lobb RR; Cook HT; Pusey CD
    Nephron Exp Nephrol; 2003; 95(3):e100-10. PubMed ID: 14646362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Butein ameliorates experimental anti-glomerular basement membrane (GBM) antibody-associated glomerulonephritis in rats (1).
    Hayashi K; Nagamatsu T; Honda S; Suzuki Y
    Jpn J Pharmacol; 1996 Jan; 70(1):55-64. PubMed ID: 8822089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis.
    Kawasaki K; Yaoita E; Yamamoto T; Tamatani T; Miyasaka M; Kihara I
    J Immunol; 1993 Feb; 150(3):1074-83. PubMed ID: 8093706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effects of ulinastatin on experimental crescentic glomerulonephritis in rats.
    Koizumi R; Kanai H; Maezawa A; Kanda T; Nojima Y; Naruse T
    Nephron; 2000 Apr; 84(4):347-53. PubMed ID: 10754412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic effects and mechanism of conditioned media from human mesenchymal stem cells on anti-GBM glomerulonephritis in WKY rats.
    Iseri K; Iyoda M; Ohtaki H; Matsumoto K; Wada Y; Suzuki T; Yamamoto Y; Saito T; Hihara K; Tachibana S; Honda K; Shibata T
    Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1182-91. PubMed ID: 27053690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.
    Tang WW; Feng L; Vannice JL; Wilson CB
    J Clin Invest; 1994 Jan; 93(1):273-9. PubMed ID: 7904269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of experimental crescentic glomerulonephritis by deoxyspergualin.
    Lan HY; Zarama M; Nikolic-Paterson DJ; Kerr PG; Atkins RC
    J Am Soc Nephrol; 1993 May; 3(11):1765-74. PubMed ID: 8329671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic effect of all-trans retinoic acid on rats with anti-GBM antibody glomerulonephritis.
    Oseto S; Moriyama T; Kawada N; Nagatoya K; Takeji M; Ando A; Yamamoto T; Imai E; Hori M
    Kidney Int; 2003 Oct; 64(4):1241-52. PubMed ID: 12969142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of TJN-598, a new selective phosphodiesterase type IV inhibitor on anti-Thy1 nephritis in rats.
    Sadakane C; Kase Y; Koseki J; Hasegawa Y; Shindo S; Maruyama H; Takeda S; Takeda H; Hattori T
    Clin Exp Nephrol; 2011 Feb; 15(1):14-24. PubMed ID: 20820840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue plasminogen activator therapy of rabbit nephrotoxic nephritis.
    Zoja C; Corna D; Macconi D; Zilio P; Bertani T; Remuzzi G
    Lab Invest; 1990 Jan; 62(1):34-40. PubMed ID: 1688634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific type IV phosphodiesterase inhibitor ameliorates thioacetamide-induced liver injury in rats.
    Matsuhashi T; Otaka M; Odashima M; Jin M; Komatsu K; Konishi N; Wada I; Sato T; Horikawa Y; Ohba R; Oyake J; Hatakeyama N; Watanabe S
    J Gastroenterol Hepatol; 2005 Jan; 20(1):135-40. PubMed ID: 15610458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist.
    Lan HY; Nikolic-Paterson DJ; Zarama M; Vannice JL; Atkins RC
    Kidney Int; 1993 Feb; 43(2):479-85. PubMed ID: 8441245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intrinsic renal cells are the major source of tumor necrosis factor contributing to renal injury in murine crescentic glomerulonephritis.
    Timoshanko JR; Sedgwick JD; Holdsworth SR; Tipping PG
    J Am Soc Nephrol; 2003 Jul; 14(7):1785-93. PubMed ID: 12819238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventive and therapeutic effects of imatinib in Wistar-Kyoto rats with anti-glomerular basement membrane glomerulonephritis.
    Iyoda M; Shibata T; Kawaguchi M; Yamaoka T; Akizawa T
    Kidney Int; 2009 May; 75(10):1060-70. PubMed ID: 19242505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis.
    Lan HY; Nikolic-Paterson DJ; Atkins RC
    Lab Invest; 1992 Dec; 67(6):743-51. PubMed ID: 1460865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventive effect of rolipram, a phosphodiesterase 4 enzyme inhibitor, on oxidative renal injury in acute ascending pyelonephritis model in rats.
    Görür S; Celik S; Hakverdi S; Aslantaş O; Erdoğan S; Aydin M; Ocak S; Namik Kiper A
    Urology; 2008 Oct; 72(4):743-8. PubMed ID: 18554698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of a novel and selective inhibitor of inducible nitric oxide synthase on experimental crescentic glomerulonephritis in WKY rats.
    Ogawa D; Shikata K; Matsuda M; Okada S; Usui H; Wada J; Taniguchi N; Makino H
    Nephrol Dial Transplant; 2002 Dec; 17(12):2117-21. PubMed ID: 12454221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective inhibition of phosphodiesterase-4 ameliorates chronic colitis and prevents intestinal fibrosis.
    Videla S; Vilaseca J; Medina C; Mourelle M; Guarner F; Salas A; Malagelada JR
    J Pharmacol Exp Ther; 2006 Feb; 316(2):940-5. PubMed ID: 16254133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage-induced glomerular fibrin deposition in experimental glomerulonephritis in the rabbit.
    Holdsworth SR; Tipping PG
    J Clin Invest; 1985 Oct; 76(4):1367-74. PubMed ID: 4056035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis.
    Shimizu A; Masuda Y; Mori T; Kitamura H; Ishizaki M; Sugisaki Y; Fukuda Y
    J Am Soc Nephrol; 2004 Oct; 15(10):2655-65. PubMed ID: 15466270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.